We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Industry

Image: Global clinical chemistry analyzer market was valued at over USD 12 billion in 2021 (Photo courtesy of Unsplash)

Global Clinical Chemistry Analyzer Market Driven by Higher Testing Volume and Shorter TAT Due to Automation

In recent decades, the clinical chemistry instrumentation business has seen a rapid evolution of technological improvements. Novel features, such as closed tube sampling, automated maintenance processes, streamlined calibration, and internet-based remote diagnostics, have been introduced with each new system generation. These intend to help laboratories better meet the needs of physicians and patients while creating efficiencies, driving quality, lowering costs, and addressing workforce fluctuations. As a result, the global clinical chemistry analyzer market was valued at over USD 12 billion in 2021 and is anticipated to grow at a CAGR of 4.8% over the forecast period (2022-2030). More...
28 Mar 2022
Image: NAVIFY Digital Pathology enhances efficiency of pathology laboratory workflow (Photo courtesy of Roche)

Roche and BMS Collaborate on Digital Pathology Algorithms and Cancer Diagnostic Assays

Advances in computation and artificial intelligence (AI) in digital pathology are showing promise to meet the demand for more accurate and comprehensive assessment of pathology results to enable improved patient outcomes. Roche (Basel, Switzerland; www.roche.com) has entered into a collaboration with Bristol Myers Squibb (BMY, New York, NY, USA) to support the advancement of two assays for use in clinical trials with the development and deployment of two new digital pathology algorithms. More...
28 Mar 2022
Image: Proscia and Visiopharm share insights about future of digital pathology at USCAP 2022 (Photo courtesy of Visiopharm)

AI-Powered Pathology to Drive Insight in Cancer Diagnosis

Driven by a growing base of evidence on the economic and clinical benefits of adoption, leading laboratories are increasingly looking to adopt AI in routine practice to optimize operations and improve patient care. A key barrier to deriving the full value of AI is the lab’s ability to seamlessly integrate this diverse range of applications into routine operations. Now, a strategic partnership will deliver integrated AI-enabled solutions that aim to improve clinical decision making for cancer care. More...
25 Mar 2022
Image: Concentriq Dx digital pathology platform (Photo courtesy of Proscia)

Siemens Enters Digital Pathology Market with Proscia’s Concentriq Dx Platform

Siemens Healthineers (Erlangen, Germany) and Proscia (Philadelphia, PA, USA) have entered into a multi-year OEM agreement under which Siemens will expand its Enterprise Imaging offering towards the global digital pathology market using Proscia’s Concentriq Dx platform. With Proscia’s Concentriq Dx platform, Siemens is entering the digital pathology market to satiate the rampant demand and expand its Enterprise Imaging offering with industry-leading technology to realize the full value of digital pathology operations. More...
23 Mar 2022
Image: Bioperfectus has partnered with FIND to lift COVID-19 self-testing capacity in LMICs (Photo courtesy of Bioperfectus)

Bioperfectus Partners with FIND to Increase COVID-19 Self-Testing Capacity in Low and Middle-Income Countries

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China), a leading in-vitro diagnostics provider for infectious diseases, has partnered with FIND (Geneva, Switzerland), the global alliance for diagnostics, to accelerate the availability of affordable SARS-CoV-2 self-tests in low- and middle-income countries (LMICs). More...
15 Mar 2022
Image: Global blood collection devices market is projected to reach USD 7.8 billion by 2026 (Photo courtesy of Pexels)

Global Blood Collection Devices Market to Reach USD 7.8 Billion by 2026 Due to Increasing Incidence of Infectious Diseases

The global blood collection devices market is projected to register a CAGR of 6.0% from USD 5.7 billion in 2021 to USD 7.8 billion by 2026, driven primarily by the increasing incidence of infectious diseases, rising number of accidents & trauma cases, emergence of liquid biopsy tests, and demand for blood donations and blood components. However, the complexities of storage and shipping, and lack of skilled professionals are expected to restrain market growth during the forecast period. More...
14 Mar 2022
Image: Collaboration to evolve use of AI-powered pathology algorithms (Photo courtesy of Cleveland Clinic)

AI-Powered Pathology Can Radically Enhance Diagnostic Accuracy and Treatment Selection

A new collaborative effort will combine artificial intelligence (AI)-based platforms with clinical expertise and multi-modal data to unlock a broad implementation of next-generation pathology diagnostics. More...
14 Mar 2022
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Online QC Software
Acusera 24•7
Steam Sterilizer
Hi Vac II Line
Prefilled Tubes
Prefilled 5.0ml Tubes


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2026 Globetech Media. All rights reserved.